Regulatory Situation of Herbal Medicines - A Worldwide Review
(1998; 49 pages) [French] [Spanish] Ver el documento en el formato PDF
Índice de contenido
Ver el documentoFOREWORD
Abrir esta carpeta y ver su contenidoI. INTRODUCTION
Abrir esta carpeta y ver su contenidoAfrica
Abrir esta carpeta y ver su contenidoThe Americas
Abrir esta carpeta y ver su contenidoEastern Mediterranean
Cerrar esta carpetaEurope
Ver el documentoGeneral aspects
Ver el documentoAttempts to Meet the Need for Harmonization
Ver el documentoAustria
Ver el documentoBelgium
Ver el documentoBulgaria
Ver el documentoDenmark
Ver el documentoEstonia
Ver el documentoFinland
Ver el documentoFrance
Ver el documentoGermany
Ver el documentoGreece
Ver el documentoHungary
Ver el documentoIceland
Ver el documentoIreland
Ver el documentoItaly
Ver el documentoNetherlands
Ver el documentoNorway
Ver el documentoPortugal
Ver el documentoSpain
Ver el documentoSweden
Ver el documentoSwitzerland
Ver el documentoTurkey
Ver el documentoUnited Kingdom
Abrir esta carpeta y ver su contenidoSouth East Asia
Abrir esta carpeta y ver su contenidoWestern Pacific
Ver el documentoIII. CONCLUSION
Ver el documentoIV. REFERENCES


Herbal medicines are defined as medicines the active ingredients of which are exclusively plants or plant extracts. In 1987, the Ministry of Health published the first "Avis aux fabricants" (advice to manufacturers) taking into account the fact that the directives of the EC which define pharmacotoxicological and clinical criteria required for a marketing authorization are not applicable for most herbal remedies, and the fact that frequently their efficacy cannot be demonstrated on the basis of bibliographical data. To give a better defined status to plant-based medicinal products, a list was drawn up of vegetable drugs which could be registered according to an abridged dossier. Their safety, with an optimum benefit-risk ratio, was taken into account as well as historical proof of their widespread traditional use and their well established use in self-medication. These guidelines were completed in 1990, and cover applications for marketing authorizations for new products and the validation of products already on the market [51].

This guideline includes a list of 174 plants and parts of plants with approved therapeutic indications, a list of 35 accepted therapeutic indications for minor ailments (17 for oral use, 9 for external use and 9 for both uses) with a low indication level which is introduced by "Traditionellement utilisé dans..." ("Traditionally used in ..."). Furthermore, a list of fixed combinations of plants is available and a special section on laxative herbs. The guideline is completed by a detailed description of the content of the dossier, a list of toxicological recommendations according to the preparations concerned (with special recommendations for laxatives), and rules for labelling and packaging of herbal medicines [51].

Ir a la sección anterior
Ir a la siguiente sección
El Portal de Información - Medicamentos Esenciales y Productos de Salud de la OMS fue diseñado y es mantenido por la ONG Human Info. Última actualización: le 29 octubre 2018